BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Revolutionizing Portable EEG Diagnostics Space

June 21, 2021 10:30:58

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions resulting from head trauma in contact sports are usually minor; however, some can lead to significant long-term cognitive, physical and psychosocial impairments. “Unfortunately,” observes a recent article, “at this moment, it is challenging to differentiate between the two.” CT is the most commonly used imaging procedure but is not effective when conducting a post-concussion examination. MRIs and neuropsychologic testing are somewhat more effective but are time-consuming. Even so, EEG and qualitative EEG (“QEEG”) procedures are proving valuable; their value may lie in pre- and post-concussion comparisons where pre-trauma readings would be compared to post-trauma readings of the same patient. “With portable devices, sideline-based concussion assessment could help identify indicators consistent with acute TBI [traumatic brain injury] and concussion during the game. Portable EEG diagnostics is precisely the space that BRSF aims to revolutionize. With the company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), it is now possible to conduct quick and reliable EEG testing in minutes… to diagnose concussions and other head trauma that occur on the field without transporting a patient to the hospital.”

To view the full article, visit

About Brain Scientific Inc.

Brain Scientific is a commercial-stage health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork